Editas Medicine, Inc.
Biological Products, (No Diagnostic Substances) · Cambridge, MA, United States
- PrincipalsAmy ParisonSVP, Chief Financial OfficerGilmore Neil O'NeillCEOLinda BurklyEVP, CHIEF SCIENTIFIC OFFICER
- CompanyEditas Medicine, Inc.Cambridge, MA, United States
- Phone line+1 (617) 401-9000General business
Editas Medicine, Inc. is an SEC-registered Nasdaq-listed company (ticker EDIT) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 3
Chief executive
Finance
Amy ParisonSVP, Chief Financial Officer
Everyone else on file (1)
Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Amy Parison — SVP, Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Gilmore Neil O'Neill — CEO
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Linda Burkly — EVP, CHIEF SCIENTIFIC OFFICER
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Adaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityCrispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capability